نتائج البحث

Nanopore-based targeted sequencing (NTS) for drug-resistant tuberculosis: an integrated tool for personalized treatment strategies and guidance for new drug development.

• Authors : Yang C; Department of Tuberculosis, The Second Hospital of Nanjing, Nanjing, 211100, China.; Dai G

Subjects: Tuberculosis, Multidrug-Resistant*/Tuberculosis, Multidrug-Resistant*/Tuberculosis, Multidrug-Resistant*/diagnosis ; Tuberculosis, Multidrug-Resistant*/Tuberculosis, Multidrug-Resistant*/Tuberculosis, Multidrug-Resistant*/drug therapy ; Tuberculosis, Multidrug-Resistant*/Tuberculosis, Multidrug-Resistant*/Tuberculosis, Multidrug-Resistant*/microbiology

• Source: BMC infectious diseases [BMC Infect Dis] 2025 Jul 01; Vol. 25 (1), pp. 861. Date of Electronic Publication: 2025 Jul 01.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334

تفاصيل العنوان

Whole-genome sequencing for analyzing the transmission characteristics of drug-resistant Mycobacterium tuberculosis in Ganzhou, China.

• Authors : Wang, Juexin¹ (AUTHOR) ; Chen, Chan² (AUTHOR) ; Fang, Huan¹ (AUTHOR)

• Source: BMC Infectious Diseases. 7/28/2025, Vol. 25 Issue 1, p1-11. 11p.

تفاصيل العنوان

Changes in antibiotic use associated with the National Centralized Drug Procurement policy in China from 2019 to 2023.

• Authors : Lin F; School of International Pharmaceutical Business, China Pharmaceutical University, Nanjing, China.; Li H

Subjects: Anti-Bacterial Agents*/Anti-Bacterial Agents*/Anti-Bacterial Agents*/therapeutic use ; Antimicrobial Stewardship* ; Health Policy*

• Source: Scientific reports [Sci Rep] 2025 Jul 19; Vol. 15 (1), pp. 26226. Date of Electronic Publication: 2025 Jul 19.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Factors associated with post-treatment resorption of lung cavities in individuals with first episodes of drug-sensitive cavitary pulmonary tuberculosis in China.

• Authors : Li X; Department of Tuberculosis, Haihe Hospital, Tianjin University, Tianjin, 300350, China.; Ye J

Subjects: Tuberculosis, Pulmonary*/Tuberculosis, Pulmonary*/Tuberculosis, Pulmonary*/drug therapy ; Tuberculosis, Pulmonary*/Tuberculosis, Pulmonary*/Tuberculosis, Pulmonary*/pathology ; Tuberculosis, Pulmonary*/Tuberculosis, Pulmonary*/Tuberculosis, Pulmonary*/diagnostic imaging

• Source: BMC infectious diseases [BMC Infect Dis] 2025 Jul 07; Vol. 25 (1), pp. 899. Date of Electronic Publication: 2025 Jul 07.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334

تفاصيل العنوان

Pharmacokinetics/Pharmacodynamics and Therapeutic Drug Monitoring of Ceftazidime/Avibactam in Patients With Gram‐Negative Bacterial Infections.

• Authors : Han, Ruiying^1,2; Sun, Dan¹; Zhang, Ying¹

• Source: Journal of Clinical Pharmacy & Therapeutics. 7/16/2025, Vol. 2025, p1-8. 8p.

تفاصيل العنوان

HIV-1 subtype distribution and drug resistance profiles among PLWHA with detectable viremia in Henan Province, China, 2023.

• Authors : Liu J; Affiliated Infectious Diseases Hospital of Zhengzhou University (Henan Infectious Diseases Hospital, The SixthPeople's Hospital of Zhengzhou), Erqi District, No.29, Jingguang South Road, Zhengzhou, 450000, China.; Fu C

Subjects: HIV-1*/HIV-1*/HIV-1*/genetics ; HIV-1*/HIV-1*/HIV-1*/drug effects ; HIV-1*/HIV-1*/HIV-1*/classification

• Source: Scientific reports [Sci Rep] 2025 May 22; Vol. 15 (1), pp. 17825. Date of Electronic Publication: 2025 May 22.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Risk factors for poor outcomes in patients with drug-resistant tuberculosis: a 6-year multicenter prospective study in Zhejiang, China.

• Authors : Feng X; State Key Laboratory for Diagnosisandaqtreatment of Infectious Diseasescollaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, the First Affiliated Hospital, Zhejiang University School of Medicine, No. 79 Qingchun Road, Hangzhou, 310003, China.; Hong L

Subjects: Tuberculosis, Multidrug-Resistant*/Tuberculosis, Multidrug-Resistant*/Tuberculosis, Multidrug-Resistant*/drug therapy ; Tuberculosis, Multidrug-Resistant*/Tuberculosis, Multidrug-Resistant*/Tuberculosis, Multidrug-Resistant*/epidemiology ; Tuberculosis, Multidrug-Resistant*/Tuberculosis, Multidrug-Resistant*/Tuberculosis, Multidrug-Resistant*/microbiology

• Source: BMC infectious diseases [BMC Infect Dis] 2025 Mar 27; Vol. 25 (1), pp. 422. Date of Electronic Publication: 2025 Mar 27.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334

تفاصيل العنوان

Baseline keratin-18 level and risk of anti-tuberculosis drug-induced liver injury: An individual matched case-control study.

• Authors : Han B; Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, China.; Zhu M

Subjects: Chemical and Drug Induced Liver Injury*/Chemical and Drug Induced Liver Injury*/Chemical and Drug Induced Liver Injury*/blood ; Chemical and Drug Induced Liver Injury*/Chemical and Drug Induced Liver Injury*/Chemical and Drug Induced Liver Injury*/diagnosis ; Chemical and Drug Induced Liver Injury*/Chemical and Drug Induced Liver Injury*/Chemical and Drug Induced Liver Injury*/etiology

• Source: Pakistan journal of pharmaceutical sciences [Pak J Pharm Sci] 2025 May-Jun; Vol. 38 (3), pp. 751-758.Publisher: Faculty of Pharmacy, University of Karachi Country of Publication: Pakistan NLM ID: 9426356 Publication Model: Print Cited Medium: Internet

تفاصيل العنوان

PBPK Modeling: Empowering Drug Development and Precision Dosing in China.

• Authors : Yang D; Department of Clinical Pharmacy and Pharmacy Administration, School of Pharmacy, Fudan University, Shanghai, China.; Li J

Subjects: Drug Development*/Drug Development*/Drug Development*/methods ; Models, Biological* ; Pharmacokinetics*

• Source: CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2025 May; Vol. 14 (5), pp. 828-839. Date of Electronic Publication: 2025 Feb 18.Publisher: Wiley Country of Publication: United States NLM ID: 101580011 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Surveillance and analysis of drug resistance and drug resistance levels in multidrug resistant tuberculosis on the tropical islands of China.

• Authors : Wang J; Department of Clinical Laboratory, The Second Affiliated Hospital of Hainan Medical University, Haikou, 570311, People's Republic of China.; Dong J

Subjects: Tuberculosis, Multidrug-Resistant*/Tuberculosis, Multidrug-Resistant*/Tuberculosis, Multidrug-Resistant*/epidemiology ; Tuberculosis, Multidrug-Resistant*/Tuberculosis, Multidrug-Resistant*/Tuberculosis, Multidrug-Resistant*/microbiology ; Tuberculosis, Multidrug-Resistant*/Tuberculosis, Multidrug-Resistant*/Tuberculosis, Multidrug-Resistant*/drug therapy

• Source: BMC infectious diseases [BMC Infect Dis] 2025 Aug 01; Vol. 25 (1), pp. 973. Date of Electronic Publication: 2025 Aug 01.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334

تفاصيل العنوان